Your browser doesn't support javascript.
loading
A novel test for recessive contributions to complex diseases implicates Bardet-Biedl syndrome gene BBS10 in idiopathic type 2 diabetes and obesity.
Lim, Elaine T; Liu, Yangfan P; Chan, Yingleong; Tiinamaija, Tuomi; Käräjämäki, AnnMari; Madsen, Erik; Altshuler, David M; Raychaudhuri, Soumya; Groop, Leif; Flannick, Jason; Hirschhorn, Joel N; Katsanis, Nicholas; Daly, Mark J.
  • Lim ET; Division of Genetics and Genomics, The Manton Center for Orphan Disease Research, Boston Children's Hospital, Boston, MA 02115, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815-6789, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA; Program in Medical and Populat
  • Liu YP; Center for Human Disease Modeling, Duke University Medical Center, Duke University, Durham, NC 27710, USA.
  • Chan Y; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA; Program in Medical and Population Genetics, Broad Institute, Cambridge, MA 02142, USA; Divisions of Endocrinology and Genetics and Center for Basic and Translational Obesity Research, Boston Children's Hospital, Boston, MA 02115,
  • Tiinamaija T; Department of Internal Medicine/Diabetology, Helsinki University Central Hospital, Helsinki 00029, Finland; The Institute for Diabetes Genetics, Folkhalsan Research Center, University of Helsinki, Helsinki 00014, Finland; Research Program for Diabetes and Obesity, University of Helsinki, Haartmanink
  • Käräjämäki A; Department of Primary Health Care, Vaasa Central Hospital, Hietalahdenkatu 2-4, 65 130 Vaasa, Finland; Diabetes Center, Vaasa Health Care Center, Sepänkyläntie 14-16, 65 100 Vaasa, Finland.
  • Madsen E; Center for Human Disease Modeling, Duke University Medical Center, Duke University, Durham, NC 27710, USA.
  • Altshuler DM; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA; Program in Medical and Population Genetics, Broad Institute, Cambridge, MA 02142, USA; Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Raychaudhuri S; Program in Medical and Population Genetics, Broad Institute, Cambridge, MA 02142, USA; Divisions of Genetics and Rheumatology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Arthritis Research UK Epidemiology Unit, Centre for Musculoskeletal Rese
  • Groop L; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki 00014, Finland; Lund University Diabetes Center, Department of Clinical Sciences, Diabetes & Endocrinology, Skåne University Hospital, Lund University, Malmö 205 02, Sweden.
  • Flannick J; Program in Medical and Population Genetics, Broad Institute, Cambridge, MA 02142, USA; Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Hirschhorn JN; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA; Program in Medical and Population Genetics, Broad Institute, Cambridge, MA 02142, USA; Divisions of Endocrinology and Genetics and Center for Basic and Translational Obesity Research, Boston Children's Hospital, Boston, MA 02115,
  • Katsanis N; Center for Human Disease Modeling, Duke University Medical Center, Duke University, Durham, NC 27710, USA.
  • Daly MJ; Program in Medical and Population Genetics, Broad Institute, Cambridge, MA 02142, USA; Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA. Electronic address: mjdaly@atgu.mgh.harvard.edu.
Am J Hum Genet ; 95(5): 509-20, 2014 Nov 06.
Article en En | MEDLINE | ID: mdl-25439097
ABSTRACT
Rare-variant association studies in common, complex diseases are customarily conducted under an additive risk model in both single-variant and burden testing. Here, we describe a method to improve detection of rare recessive variants in complex diseases termed RAFT (recessive-allele-frequency-based test). We found that RAFT outperforms existing approaches when the variant influences disease risk in a recessive manner on simulated data. We then applied our method to 1,791 Finnish individuals with type 2 diabetes (T2D) and 2,657 matched control subjects. In BBS10, we discovered a rare variant (c.1189A>G [p.Ile397Val]; rs202042386) that confers risk of T2D in a recessive state (p = 1.38 × 10(-6)) and would be missed by conventional methods. Testing of this variant in an established in vivo zebrafish model confirmed the variant to be pathogenic. Taken together, these data suggest that RAFT can effectively reveal rare recessive contributions to complex diseases overlooked by conventional association tests.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Predisposición Genética a la Enfermedad / Diabetes Mellitus Tipo 2 / Estudio de Asociación del Genoma Completo / Chaperoninas del Grupo II / Genes Recesivos / Modelos Genéticos / Obesidad Tipo de estudio: Etiology_studies Límite: Animals / Humans País como asunto: Europa Idioma: En Año: 2014 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Predisposición Genética a la Enfermedad / Diabetes Mellitus Tipo 2 / Estudio de Asociación del Genoma Completo / Chaperoninas del Grupo II / Genes Recesivos / Modelos Genéticos / Obesidad Tipo de estudio: Etiology_studies Límite: Animals / Humans País como asunto: Europa Idioma: En Año: 2014 Tipo del documento: Article